deltatrials
Completed PHASE1 NCT01840540

MSC for Occlusive Disease of the Kidney

Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis

Sponsor: Mayo Clinic

Conditions Atherosclerotic Renal Artery Stenosis Ischemic Nephropathy Renovascular Hypertension
Interventions Arterial infusion of autologous mesenchymal stem cells
Updated 7 times since 2017 Last updated: Aug 4, 2017 Started: Apr 30, 2013 Primary completion: Mar 31, 2014 Completion: Apr 30, 2017

A PHASE1 clinical study on Atherosclerotic Renal Artery Stenosis and Ischemic Nephropathy, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 7 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

  1. Feb 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Rochester, United States